Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06378749 · ClinicalTrials.gov registry record · NA

Previvors Recharge: A Resilience Program for Cancer Previvors

A NA study, sponsored by Pro-Change Behavior Systems.

Completed
Registry status
NA
Development phase
138
Enrollment target

NCT06378749 is a NA study that has completed, run by Pro-Change Behavior Systems. The registered enrollment target is 138 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06378749, a NA study, has completed, sponsored by Pro-Change Behavior Systems.

COMPLETED
Registry status
NA
Development phase
138 participants
Enrollment target

Study Summary

It is estimated that 1 in 279 people may be carriers of a Hereditary Cancer Syndromes (HCS), a cancer risk that is associated with germline mutations (inherited genetic mutations passed directly from a parent to a child that create a genetic predisposition to certain types of cancer). Individuals with an HCS who have never been diagnosed with cancer (Previvors) have up to an 80% lifetime risk of developing cancer and are at an increased risk of developing multiple primary cancers during their lifetime, often with onset at an early age. Previvors face multiple forms of adversity, including a multitude of annual cancer screenings and the uncertainty of not only their own health but the health of affected family members. This study will examine the acceptability and preliminary effects of PreCharge, a resilience-boosting solution specifically designed for Previvors and delivered primarily via bi-directional text messaging. PreCharge uses proven approaches to behavior change tailoring to increase resilience by promoting a positive mindset, strong social connections, and a deep sense of meaning and purpose while also proactively addressing scanxiety. Up to 150 Hereditary Cancer Previvors will be recruited for a 30-day pilot test. Participants will complete a baseline assessment, and then be provided with 30 days of access to the PreCharge program. At the end of the 30 days, they will be prompted to complete a follow-up assessment. Outcomes to be examined will include pre-post changes on the Connor Davidson Resilience Scale.

Interventions

  • BEHAVIORAL PreCharge

Trial Details

FieldValue
Enrollment Target 138 participants
Start Date 2024-04-11
Est. Completion 2024-09-27
Phase NA

Sponsor

Pro-Change Behavior Systems

11 total trials

What the Registry Record Tells You About NCT06378749

The ClinicalTrials.gov registry entry for NCT06378749 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 138 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pro-Change Behavior Systems, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which PreCharge is the first listed.

NCT06378749 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06378749 about?

NCT06378749 is a clinical study titled "Previvors Recharge: A Resilience Program for Cancer Previvors". It is estimated that 1 in 279 people may be carriers of a Hereditary Cancer Syndromes (HCS), a cancer risk that is associated with germline mutations (inherited genetic mutations passed directly from a parent to a child that create a genetic predisposition to certain types of cancer). Individuals wi...

What is the current status of trial NCT06378749?

This trial is currently completed. It is a NA study. The enrollment target is 138 participants. The study started on 2024-04-11. Estimated completion is 2024-09-27.

What interventions are being tested in trial NCT06378749?

The interventions under investigation include: PreCharge (BEHAVIORAL).

Who is sponsoring clinical trial NCT06378749?

This trial is sponsored by Pro-Change Behavior Systems, which has 11 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.